Johnson & Johnson corona vaccine approved in the EU

In addition to the vaccines from AstraZeneca, BioNTech/Pfizer and Moderna, Johnson & Johnson, another corona vaccine, was approved by the EMA this week. What are the benefits of the vaccine and how reliable is it?

Johnson  & Johnson’s vaccine  is already approved in the United States. In Germany, the first vaccine doses should arrive in April.

These are the benefits of the Johnson & Johnson vaccine

The vector vaccine stands out from other vaccines particularly in terms of storage and the number of vaccine doses. Unlike Moderna and BioNTech/Pfizer vaccines, the vaccine can be   stored at normal refrigerator temperatures. In addition, one dose of the vaccine from Johnson & Johnson is sufficient for complete vaccination protection – the vaccination process does not have to be repeated. The effectiveness of the vaccine is 67 percent for moderate to severe and 85 percent for life-threatening courses of the disease.

Find out more about the Johnson and Johnson vaccine here:

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *